‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease

Global NewsWednesday, October 29, 2025 at 5:56:10 PM
PositiveHealth
‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease
Health Canada has made a significant move by approving lecanemab, the first drug aimed at slowing the progression of Alzheimer's disease. This approval is crucial as it brings hope to many patients and families affected by this debilitating condition. With lecanemab already available in countries like the U.S., U.K., Japan, Mexico, and China, its introduction in Canada marks an important step in the global fight against Alzheimer's, potentially improving the quality of life for countless individuals.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Inside factory producing fentanyl in China
NeutralHealth
A factory in China that produces fentanyl for hospitals has denied allegations that its drugs are smuggled into the U.S. This comes amid ongoing tensions, as the U.S. accuses China of manufacturing precursor chemicals for fentanyl that contribute to the opioid crisis. The report by NBC News' Janis Mackey Frayer highlights the complexities of international drug trafficking and the challenges in addressing the opioid epidemic.
Canada is likely to lose its measles elimination status. The U.S. could be next.
NegativeHealth
Canada is facing the possibility of losing its measles elimination status due to a persistent outbreak that has been ongoing for a year. This situation is concerning not just for Canada but also for the U.S., which could be next in line if vaccination rates do not improve. The implications of losing this status could lead to increased health risks and a resurgence of measles, a disease that was previously under control.
Weight loss drugs are bringing down the country's obesity rate, a survey shows
PositiveHealth
Recent findings from the Gallup National Health and Well-Being Index reveal that GLP-1 weight loss drugs are making a significant impact on the U.S. obesity rate, which has decreased from 39.9% to 37%. This is encouraging news as it suggests that medical advancements in weight management are helping to combat obesity, a major public health concern. The decline in obesity rates could lead to improved overall health outcomes for many Americans, making this a noteworthy development in the fight against obesity.
What is Mpox and why are cases rising in Europe?
PositiveHealth
Health officials in the UK are urging gay, bisexual, and other men who have sex with men to get vaccinated against Mpox as cases rise in Europe. This proactive approach is crucial in controlling the spread of the virus and protecting vulnerable communities. By encouraging vaccination, health authorities aim to reduce transmission rates and safeguard public health, highlighting the importance of awareness and preventive measures.
Latest from Health
Novo Nordisk launched a bid valued at up to $9 billion for obesity-drug developer Metsera, hoping to trump an already agreed-on deal Pfizer made for the U.S. company
PositiveHealth
Novo Nordisk has made a bold move by launching a bid of up to $9 billion for Metsera, a company known for its obesity drugs. This strategic acquisition aims to outmaneuver Pfizer, which has already secured a deal with Metsera. The competition between these pharmaceutical giants highlights the growing importance of obesity treatments in the healthcare market, as both companies seek to expand their portfolios and enhance their positions in this lucrative sector.
Judge to consider demand to force the government to keep funding SNAP food aid despite the shutdown
NeutralHealth
A federal judge in Boston is set to review a motion that could compel the Trump administration to maintain funding for the SNAP food aid program amid the ongoing government shutdown. This is significant as SNAP provides essential support to millions of Americans facing food insecurity, and any disruption in funding could have serious implications for those relying on this assistance.
R.F.K. Jr. Adviser Calley Means Has Left the White House
NeutralHealth
Calley Means, an adviser to Robert F. Kennedy Jr., has officially left his position at the White House. This change comes amid ongoing discussions about the political landscape and the role of advisers in shaping policy. While the impact of Means' departure is yet to be fully understood, it highlights the fluid nature of political appointments and the challenges faced by those in advisory roles.
Trump pushes an end to medical care for transgender youth nationally
NegativeHealth
The White House's recent decision to prohibit hospitals from receiving Medicare and Medicaid payments for treating transgender youth is raising significant concerns. This policy not only impacts the healthcare access of transgender children but also extends to those with private insurance, potentially leaving many without essential medical support. This move is seen as a setback for transgender rights and healthcare equity, highlighting the ongoing debate over the treatment of transgender individuals in the U.S.
How Americans feel about changing the clocks, according to a new AP-NORC poll
NeutralHealth
A recent AP-NORC poll reveals mixed feelings among Americans about the end of daylight saving time, a weekend that many dread despite the promise of an extra hour of sleep. This annual clock change sparks discussions about its impact on daily life, sleep patterns, and overall well-being, making it a significant topic as people adjust to the darker evenings.
Candy is dandy but trick or treat for UNICEF has heft. And this year it turns 75!
PositiveHealth
This year marks the 75th anniversary of Trick or Treat for UNICEF, a campaign that encourages children to collect coins for needy kids around the world. Originating from a couple's desire to give Halloween a deeper purpose, this initiative has grown in significance, especially in today's world where many children face hardships. It's a wonderful reminder that even small actions can make a big difference in the lives of others.